EVALUATION OF THE ANTIBACTERIAL ACTIVITY OF LEAF EXTRACT OF OLEA EUROPAEA (OLIVE TREE) AGAINST SOME CLINICAL ISOLATES

ABSTRACT

This study evaluated the antibacterial activity of Olea europaea (olive) leaf extract against selected clinical bacterial isolates. The specific objectives were to conduct preliminary phytochemical screening of the extract, determine its antibacterial activity using agar-well diffusion assays, and establish the Minimum Inhibitory Concentration (MIC). An experimental laboratory-based design was employed. Fresh Olea europaea leaves were collected, authenticated, air-dried, powdered, and extracted using methanol through maceration. Antibacterial activity was tested against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Zones of inhibition were measured at different extract concentrations (100–400 mg/ml), while MIC values were determined using broth dilution. Phytochemical screening revealed the presence of alkaloids, flavonoids, tannins, saponins, phenolics, and terpenoids, with glycosides and steroids absent. The extract demonstrated concentration-dependent antibacterial activity, with the highest inhibition zones observed at 400 mg/ml: E. coli (17.4 mm), S. aureus (16.7 mm), P. aeruginosa (15.1 mm), and K. pneumoniae (16.2 mm). MIC values ranged from 50–100 mg/ml for Gram-positive organisms and 100–200 mg/ml for Gram-negative organisms. Although ciprofloxacin exhibited higher activity, the extract showed significant antibacterial effects and demonstrated both bacteriostatic and bactericidal properties depending on concentration. The study concludes that Olea europaea leaf extract possesses important phytochemicals and exhibits notable antibacterial potential against clinically relevant pathogens, supporting its traditional medicinal use. It is recommended for further pharmaceutical development, standardized extraction, and possible integration into complementary healthcare practices.

TABLE OF CONTENTS

Preliminary Pages

• Title Page
• Certification
• Dedication
• Acknowledgements
• Abstract
• Table of Contents
• List of Tables
• List of Figures
• List of Abbreviations

CHAPTER ONE: INTRODUCTION

1.1 Background of the Study
1.2 Statement of the Problem
1.3 Aim and Objectives of the Study
1.4 Research Questions
1.5 Significance of the Study
1.6 Scope of the Study
1.7 Limitations of the Study
1.8 Operational Definition of Terms

CHAPTER TWO: LITERATURE REVIEW

2.1 Introduction
2.2 The Olive Tree (Olea europaea): Botanical and Medicinal Overview
2.3 Bioactive Compounds in Olea europaea Leaves
2.4 Concept of Antibacterial Agents
2.5 Clinical Isolates: Sources and Relevance
2.6 Mechanism of Antibacterial Action of Plant Extracts
2.7 Previous Studies on Olea europaea and Other Medicinal Plants
2.8 Empirical Studies Related to Antibacterial Activity
2.9 Theoretical/Conceptual Framework

CHAPTER THREE: MATERIALS AND METHODS

3.1 Introduction
3.2 Research Design
3.3 Area of Study / Study Site
3.4 Collection and Identification of Plant Material (Olea europaea leaves)
3.5 Preparation of Plant Extract
3.6 Test Organisms (Clinical Isolates)
3.7 Antibacterial Susceptibility Testing Methods
3.7.1 Agar Well Diffusion Method (or Disc Diffusion, depending on choice)
3.7.2 Determination of Minimum Inhibitory Concentration (MIC)
3.8 Data Collection Procedures
3.9 Statistical Analysis

CHAPTER FOUR: RESULTS AND DATA PRESENTATION

4.1 Introduction
4.2 Phytochemical Composition of Olea europaea Leaf Extract
4.3 Antibacterial Activity Results (Zones of Inhibition)
4.4 MIC Values
4.5 Comparative Analysis with Standard Antibiotics
4.6 Discussion of Findings

CHAPTER FIVE: SUMMARY, CONCLUSION AND RECOMMENDATIONS

5.1 Introduction
5.2 Summary
5.3 Conclusion
5.4 Recommendations
5.5 Suggestions for Further Research

CHAPTER ONE

INTRODUCTION

1.1 Background of the Study

Infectious diseases caused by bacterial pathogens remain one of the leading causes of morbidity and mortality worldwide, especially in developing countries where access to quality healthcare and effective antibiotics is limited (Okeke et al., 2023). Over the past decades, the extensive and often inappropriate use of antibiotics in clinical, veterinary, and agricultural settings has accelerated the emergence of antimicrobial resistance (AMR), making formerly treatable infections increasingly difficult to manage (World Health Organization [WHO], 2024). According to the WHO, AMR is projected to cause up to 10 million deaths annually by 2050 if new therapeutic solutions are not discovered and applied (WHO, 2024). Resistant organisms such as Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa are now listed among critical and high-priority pathogens due to their resistance to multiple drug classes, including β-lactams and fluoroquinolones (WHO, 2024; Murray et al., 2022). This alarming situation necessitates the exploration of alternative antimicrobial agents, including those derived from plants.

Plants have historically served as sources of therapeutic compounds, with many modern antibiotics and drugs being plant-derived or plant-inspired (Ekor, 2022). Among medicinal plants, the olive tree (Olea europaea L.), a species belonging to the Oleaceae family, has been widely recognized in Mediterranean traditional medicine for its nutritional and pharmacological properties. Beyond olive oil, the leaves of the olive tree are rich in secondary metabolites such as oleuropein, hydroxytyrosol, tyrosol, and flavonoids, which exhibit diverse biological activities, including antioxidant, anti-inflammatory, antiviral, antifungal, and antibacterial effects (Esfandiary et al., 2024; Wang et al., 2023). These bioactive compounds, particularly phenolic glycosides, are known to interfere with bacterial cell wall integrity, inhibit nucleic acid synthesis, and disrupt biofilm formation, thereby impairing bacterial survival and pathogenicity (Hulankova et al., 2024).

Recent experimental studies have reported significant antibacterial activity of O. europaea leaf extracts against both Gram-positive and Gram-negative bacteria. For instance, olive-leaf extracts demonstrated inhibitory effects against Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae in both diffusion and dilution assays (Wiley, 2024; Al-Quraishy et al., 2022). The choice of extraction method and solvent system, however, plays a crucial role in determining the phytochemical yield and antimicrobial potency of the extracts. Methanolic and ethanolic extracts, in particular, have shown higher antibacterial activity compared to aqueous extracts, likely due to the greater solubility of phenolic compounds in organic solvents (Balouiri et al., 2016; Hulankova et al., 2024).

Despite these promising results, there remain knowledge gaps regarding the consistency, standardization, and clinical relevance of olive leaf extracts as antibacterial agents. Most available studies are laboratory-based, with significant variations in methodology, bacterial strains tested, and phytochemical profiling. Consequently, more systematic evaluations are needed to establish the potential of O. europaea leaves as reliable sources of antibacterial agents, especially against clinically relevant resistant strains.

Therefore, this study seeks to evaluate the antibacterial activity of O. europaea leaf extracts against selected clinical isolates using standardized microbiological techniques. By investigating the zones of inhibition, minimum inhibitory concentrations (MIC), and minimum bactericidal concentrations (MBC), the research aims to contribute to the growing body of knowledge on plant-based antimicrobials, providing insights into their potential role in addressing the global challenge of antimicrobial resistance.

1.2 Statement of the Problem

Despite abundant in-vitro reports on olive-leaf phenolics, evidence remains heterogeneous regarding (i) which extraction procedures maximize antibacterial yield, (ii) the activity spectrum against priority clinical isolates, and (iii) how extract performance compares with standard antibiotics under standardized test conditions. Many existing studies differ in solvent systems, phytochemical standardization, and susceptibility protocols, complicating cross-study comparisons and translational inference. Consequently, there is a need for a rigorous, laboratory-based evaluation of O. europaea leaf extract against representative clinical isolates (e.g., S. aureus, E. coli, K. pneumoniae, P. aeruginosa), using validated diffusion and dilution methods (zones of inhibition, MIC) and appropriate controls, to clarify antibacterial potential and practical relevance in the AMR era.

1.3 Aim and Objectives of the Study

Aim:
To evaluate the antibacterial activity of Olea europaea leaf extract against selected clinical bacterial isolates.

Specific Objectives:

1. To collect and authenticate O. europaea leaves and prepare crude extracts using defined solvent systems.
2. To conduct preliminary phytochemical screening of the extracts.
3. To determine antibacterial activity by diffusion assays (e.g., agar-well) against selected clinical isolates.
4. To determine the Minimum Inhibitory Concentration (MIC).

1.4 Research Questions

1. Do O. europaea leaf extracts exhibit measurable antibacterial activity against the selected clinical isolates?
2. Which extract/solvent system demonstrates the strongest antibacterial effect?
3. What are the MIC values of the active extracts against each test organism?
4. How does the antibacterial activity of the extracts compare with that of standard antibiotics?

1.5 Significance of the Study

This study contributes evidence to the ongoing search for plant-based antimicrobials with activity against WHO-listed priority pathogens. By employing standardized susceptibility methods (diffusion and dilution), it provides comparable data that may guide pre-formulation work or combination strategies with existing antibiotics. For laboratories and clinicians in resource-constrained settings, olive leaves represent a low-cost, locally obtainable biomass; robust data on their antibacterial potential could inform subsequent development of standardized extracts or adjunctive therapies, while also identifying limitations (e.g., potency thresholds, spectrum gaps, or biofilm resilience).

1.6 Scope of the Study

The study will focus on: (i) authenticated O. europaea leaves; (ii) preparation of one or more solvent extracts (e.g., methanol); (iii) in-vitro antibacterial assays against selected clinical isolates (e.g., S. aureus, E. coli, K. pneumoniae, P. aeruginosa); (iv) determination of zones of inhibition, MIC; and (v) comparison with reference antibiotics.

1.7 Operational Definition of Terms

Antibacterial Activity: The capacity of a substance to inhibit growth (bacteriostatic) or kill (bactericidal) bacteria, assessed here by zones of inhibition, MIC, and MBC following standard methods.

Agar-Well/Disc Diffusion: In-vitro assays where extracts diffuse through agar seeded with bacteria; activity is inferred from the diameter of the growth-inhibition zone around wells/discs.

Minimum Inhibitory Concentration (MIC): The lowest concentration of an antimicrobial that prevents visible growth of a microorganism after incubation under specified conditions.

Minimum Bactericidal Concentration (MBC): The lowest concentration resulting in ≥99.9% reduction in the original bacterial inoculum (bactericidal endpoint), determined from subcultures of MIC assay wells/tubes.

Olea europaea Leaf Extract: Crude or semi-purified preparation obtained from olive leaves using a defined solvent and method, containing phenolic compounds (e.g., oleuropein, hydroxytyrosol) associated with biological activity.

Clinical Isolates: Bacterial strains recovered from patient specimens in healthcare settings, used here as test organisms to reflect real-world pathogenic profiles.